TrialJournal of substance abuse treatment2022

Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19.

Robert Rosales et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.